Skip to main content

Month: March 2020

Vehicle Electrification Market Hit USD 53.3 Billion by 2026; Driven by Strict Government Regulations Towards the Use of Sustainable Fuel Alternatives, says Fortune Business Insights™

Pune, March 16, 2020 (GLOBE NEWSWIRE) — The global vehicle electrification market size is projected to reach USD 53.3 billion by the end of 2026. The rising concerns surrounding global warming and the effect of fuel combustion on greenhouse emissions will aid the growth of the market.According to a report published by Fortune Business Insights, titled “Vehicle Electrification Market Size, Share and Global Trend by Product Type (Start/Stop System, Electric Air Conditioner Compressor, PTC Heater, Electric Vacuum Pump, Electric Water Pump, Electric Oil Pump, Starter Motor & Alternator, Integrated Starter Generator, Actuators. By Vehicle Type (Passenger Cars, Light Commercial Vehicles & Heavy Commercial Vehicles), and Geography Forecast till 2026,” the market size was USD 27.9 billion in 2018 and will exhibit a CAGR of 8.5%...

Continue reading

Establishment Labs Reports Fourth Quarter and Full Year 2019 Financial Results

NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended December 31, 2019.Fourth Quarter and Recent Business HighlightsFull-year 2019 worldwide sales of $89.6 million, representing a 46.3% increase year-over-yearFourth quarter 2019 worldwide sales of $24.2 million, an increase of 47.9% year-over-year, and another quarter of record performanceIn January 2020, completed an over-subscribed public offering of 2,628,571 common shares, raising gross proceeds of approximately $69.0 millionU.S. development timeline for Pre-Market Authorization (PMA) submission to FDA is on trackAchieved a significant milestone...

Continue reading

Galectin Therapeutics Reports Fiscal 2019 Financial Results and Provides Business Update

NORCROSS, Ga., March 16, 2020 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended December 31, 2019. These results are included in the Company’s Annual Report on Form 10-K, which has been filed with the U.S. Securities and Exchange Commission and is available at www.sec.gov.Harold H. Shlevin, Ph.D., President and Chief Executive Officer of Galectin Therapeutics, said, “The focus of the past few months has been on finalizing the refinements to our planned NASH-RX trial based on feedback from the U.S. Food and Drug Administration (FDA). Our Adaptive-Designed Phase 2b/3 trial protocol is nearly complete, and we anticipate initiating the trial in the second quarter of...

Continue reading

TREVI THERAPEUTICS ANNOUNCES FOURTH QUARTER AND YEAR END 2019 FINANCIAL RESULTS AND CORPORATE UPDATE

Enrollment in PRISM Study Progressing – Sample Size Re-estimation Planned for mid-2020Expect to Report Top-Line Data in both PN and IPF-Cough Trials in Second Half of 2020Cash Position of $57.3 Million Expected to Fund Operations into the Third Quarter of 2021NEW HAVEN, Conn., March 16, 2020 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced financial results for the quarter and year ended December 31, 2019, as well as recent business highlights.“We made substantial progress in 2019 advancing the development of nalbuphine ER across our clinical indications and expect 2020 to be an important year for Trevi with clinical data expected in our...

Continue reading

Tree Island Steel Announces Quarterly Dividend

VANCOUVER, British Columbia, March 16, 2020 (GLOBE NEWSWIRE) — Tree Island Steel Ltd. (“Tree Island” or the “Company”) (TSX:TSL) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.02 per share on the issued and outstanding Common Shares of the Company, payable on April 15, 2020, to holders of record at the close of business on March 31, 2020.About Tree Island SteelTree Island Steel, headquartered in Richmond, British Columbia, since 1964, through its four operating facilities in Canada and the United States, produces wire products for a diverse range of industrial, residential construction, commercial construction and agricultural applications. Its products include galvanized wire, bright wire; a broad array of fasteners, including packaged, collated and bulk nails; stucco reinforcing products;...

Continue reading

Alexander Salgado, CEO and Co-Founder of Veritas Farms is Featured in a New Interview at SmallCapVoice.com

AUSTIN, Texas, March 16, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. and Veritas Farms Inc. (OTC.QB VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, announced today that Alexander Salgado, CEO and co-founder of Veritas Farms is featured in a new audio interview at SmallCapVoice.com.The interview can be heard at: https://www.smallcapvoice.com/smallcapvoice-interview-veritas-farms-vfrm.Alexander Salgado called in to SmallCapvoice.com, Inc. to go over the business model and markets for the Company. In addition, Salgado outlined the milestones achieved for the Company in 2019 and highlighted the goals for the Company in 2020. So far in 2020, VFRM has been prolific with their news flow and efforts. The...

Continue reading

Beyond Air Submits Investigational Device Exemption (IDE) to the United States Food and Drug Administration (FDA) for the Treatment of COVID-19 Patients

LungFit™ BRO system to be used in proposed study to treat COVID-19 patientsGrant applications have been submitted to the Biomedical Advance Research and Development Authority (BARDA), a division of Health and Human Services (HHS)Second trial design being vetted to investigate use in patients exposed to severe acute respiratory syndrome 2 (SARS-CoV-2), but not infectedCompany to host a conference call today at 8:30 am ET to discuss these developmentsGARDEN CITY, N.Y. and REHOVOT, Israel, March 16, 2020 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including, serious lung infections and pulmonary hypertension, and gaseous NO for the treatment of solid tumors,...

Continue reading

OCEANFIRST BANK ANNOUNCES INITIATIVES TO ASSIST CUSTOMERS, EMPLOYEES AND COMMUNITIES AFFECTED BY COVID-19

RED BANK, N.J., March 16, 2020 (GLOBE NEWSWIRE) — OceanFirst Bank N.A. (“OceanFirst” or the “Bank”), the wholly owned subsidiary of OceanFirst Financial Corp. (NASDAQ:OCFC), today announced a series of precautionary measures intended to mitigate the impact of the COVID-19 virus outbreak on its customers, employees and communities. The measures will be re-evaluated as circumstances require.“As a community-based financial institution, we believe OceanFirst can and should extend a helping hand to our customers, employees and neighbors at this difficult time,” noted Christopher D. Maher, OceanFirst Chairman, President and Chief Executive Officer. “We are offering payment relief to affected borrowers, adjusting branch operations to help protect the health and safety of customers and employees while maintaining access to our services,...

Continue reading

Kayne Anderson MLP/Midstream Investment Company Provides an Update on its Balance Sheet and its March Distribution

HOUSTON, March 16, 2020 (GLOBE NEWSWIRE) — Kayne Anderson MLP/Midstream Investment Company (NYSE: KYN) (the “Company”) announced today an update on its balance sheet and leverage levels. The Company also announced revised timing for the distribution originally scheduled to be paid on March 31, 2020.Equity prices for midstream energy companies have been extremely volatile during the first two weeks of March – the Alerian MLP Index declined 38% over this time period. In response to the recent record market volatility, the Company has proactively taken steps to increase its cash position and reduce leverage levels. Since February 29, 2020, the Company has reduced outstanding indebtedness by $125 million and, as of March 13, 2020, has no borrowings outstanding on its unsecured revolving credit facility or its term loan. After taking...

Continue reading

Teleste to provide on-board solution to Alstom’s Avelia Horizon very high-speed trains in France

TELESTE CORPORATION     INVESTOR NEWS     16.3.2020   AT 14.00 EETTELESTE TO PROVIDE ON-BOARD SOLUTION TO ALSTOM’S AVELIA HORIZON VERY HIGH-SPEED TRAINS IN FRANCEAlstom has selected Teleste’s on-board solution for the company’s next-generation very high-speed trains, designed for the French national railway operator SNCF Mobilités. Teleste will provide the on-board solution to Alstom’s very high-speed trains, which will be delivered to the French national railway operator SNCF Mobilités. With the deployments starting in 2021, Alstom’s order covers the equipment of 50 double-decker very high-speed trains and includes a further option of 50 additional trainsets.Teleste’s deployment for the trains will include passenger information management functions and a new interface for passenger information control....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.